CL2022000611A1 - Hidrogel superporoso plastificado - Google Patents

Hidrogel superporoso plastificado

Info

Publication number
CL2022000611A1
CL2022000611A1 CL2022000611A CL2022000611A CL2022000611A1 CL 2022000611 A1 CL2022000611 A1 CL 2022000611A1 CL 2022000611 A CL2022000611 A CL 2022000611A CL 2022000611 A CL2022000611 A CL 2022000611A CL 2022000611 A1 CL2022000611 A1 CL 2022000611A1
Authority
CL
Chile
Prior art keywords
plasticized
hydrogel material
superporous hydrogel
superporous
plasticization
Prior art date
Application number
CL2022000611A
Other languages
English (en)
Inventor
Xue Min
Anthony John Fitzpatrick
Jan Tadeusz Czernuszka
Camilla Easter
Original Assignee
Oxford Medical Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Medical Products Ltd filed Critical Oxford Medical Products Ltd
Publication of CL2022000611A1 publication Critical patent/CL2022000611A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2333/24—Homopolymers or copolymers of amides or imides
    • C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2433/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2433/24—Homopolymers or copolymers of amides or imides
    • C08J2433/26—Homopolymers or copolymers of acrylamide or methacrylamide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona un proceso para preparar un material de hidrogel superporoso plastificado, que comprende someter el material de hidrogel inicial a tratamiento con una solución ácida, una solución de sal de metal monovalente opcional, liofilización y plastificación. Opcionalmente, el proceso de la invención produce cuerpos de material de hidrogel superporoso plastificado moldeado, que tienen uno o más agujeros pasantes formados en ellos. El material de hidrogel superporoso plastificado de la presente invención, se puede formular como una forma de dosificación oral adecuada para suprimir el apetito y para administrar un producto farmacéutico y/o nutracéutico en un cuerpo humano o animal.
CL2022000611A 2019-10-11 2022-03-11 Hidrogel superporoso plastificado CL2022000611A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201914779A GB201914779D0 (en) 2019-10-11 2019-10-11 Polymer compositions

Publications (1)

Publication Number Publication Date
CL2022000611A1 true CL2022000611A1 (es) 2023-04-14

Family

ID=68619695

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022000611A CL2022000611A1 (es) 2019-10-11 2022-03-11 Hidrogel superporoso plastificado

Country Status (9)

Country Link
US (1) US20240092977A1 (es)
EP (1) EP4041806A1 (es)
JP (1) JP2022551908A (es)
CN (1) CN113613631A (es)
AU (1) AU2020365048A1 (es)
BR (1) BR112022004836A2 (es)
CL (1) CL2022000611A1 (es)
GB (1) GB201914779D0 (es)
WO (1) WO2021069751A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116392130B (zh) * 2023-06-07 2023-09-08 广州思德医疗科技有限公司 一种食管测压装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1253147C (zh) * 2003-08-13 2006-04-26 复旦大学 一种超多孔水凝胶复合物,其制备方法及其在药剂学中的应用
EP2799474B1 (en) * 2011-12-28 2020-05-20 Kuraray Co., Ltd. Manufacturing process for shaped article made of porous hydrogel
GB201711644D0 (en) * 2017-07-19 2017-08-30 Satie8 Ltd Polymer Compositions

Also Published As

Publication number Publication date
JP2022551908A (ja) 2022-12-14
GB201914779D0 (en) 2019-11-27
US20240092977A1 (en) 2024-03-21
EP4041806A1 (en) 2022-08-17
BR112022004836A2 (pt) 2022-06-07
WO2021069751A1 (en) 2021-04-15
AU2020365048A1 (en) 2022-03-31
CN113613631A (zh) 2021-11-05

Similar Documents

Publication Publication Date Title
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
AR106582A1 (es) Formulaciones subcutáneas de anticuerpos anti-cd38 y sus usos
CR20130377A (es) Métodos y productos de fármaco para tratar enfermedad de alzheimer
NZ595189A (en) Combination therapy with thiocolchicine derivatives
MX2022009155A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
EP2460403A4 (en) ANIMAL MODEL OF LIVER CANCER WITH STATATO-HEPATITIS
BR112017009584A2 (pt) tratamento de retinite pigmentosa com n-acetilcisteína amida
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
CY1122899T1 (el) Υδατικη συσταση περιλαμβανουσα παρακεταμολη και ιβουπροφαινη
MX2021002321A (es) Nuevos metodos.
BR112015023481A2 (pt) composição de lipossoma de liberação controlada de fármaco
CO2021000923A2 (es) Formulaciones de un inhibidor de axl/mer
AR112166A1 (es) Composiciones terapéuticas y métodos para el tratamiento de hepatitis b
CL2022000611A1 (es) Hidrogel superporoso plastificado
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
BR112019005456A2 (pt) composição farmacêutica e método para tratamento de esteatose hepática não alcoólica
UY37518A (es) Formas de dosificación de liberación modificada gastroretentivas para oprozomib y proceso para su fabricación
CO2018010142A2 (es) Proceso de preparación de fórmulas solidas de mesalazina
CY1120282T1 (el) Φαρμακευτικη συνθεση κιτρικης σιλδεναφιλης με την μορφη ενος εναιωρηματος για εκ του στοματος χρηση
BR112018002433A2 (pt) composição farmacêutica para tratamento da enxaqueca
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor
AU2022420882A1 (en) An injectable pharmaceutical composition for the treatment of respiratory diseases in animals
MX2015017857A (es) Matrices covalentes biodegradables para el suministro de insulina por via oral dirigida al colon activado por la microbiota y proceso para su obtencion.
EA201100464A1 (ru) Фармацевтическая композиция для лечения гиперпролиферативных заболеваний и её применение
UA95686U (uk) Лікарський засіб для терапії захворювань передміхурової залози в формі супозиторія